India has no plan to allow COVID-19 booster doses
Published: November 22, 2021 19:14:14 | Updated: November 23, 2021 15:17:16
India is not considering authorising booster COVID-19 doses yet as many in the country have been naturally infected and the government believes two doses of a vaccine offers sufficient protection, for now, three sources with knowledge of the matter said.
As vaccine supplies have increased, some doctors and public health experts in India have urged the government to start a booster programme for the most vulnerable like many Western nations have done, reports Reuters.
But authorities will instead concentrate on having most of India's 944 million adults complete a two-dose vaccination by January before shifting their focus to a big expansion in exports, said the sources who are involved in vaccine-policy discussions.
So far, 81 per cent of India's adults have received at least one dose while 43 per cent have had two doses. Vaccination for people under 18 has not yet begun.
"The priority is to fully immunise the adult population," said one of the sources. The sources declined to be named as the matter was still being discussed by policymakers.
"A big majority has been naturally infected, and for them, two doses are enough. That's why we are seeing that even after recent festivals, cases are not rising."
The source said that once most adults have had two vaccine doses, the government could make boosters optional.
The health ministry did not respond to a request for comment.
India reported the most COVID-19 case and death figures in the world in April and May and government surveys have shown that nearly 70 per cent of Indians were naturally infected by July. The country has so far logged 34.5 million infections - the most after the United States - with more than 465,000 deaths.
Although India celebrated two of its biggest festivals, Diwali and Durga Puja in October and November, infections have fallen to multi-month lows.
Many Western countries are expanding their booster programmes, even for people without compromised immunity - a policy which the World Health Organisation has heavily criticised.
Indian vaccine companies like the Serum Institute of India, which produces licensed versions of the AstraZeneca and Novavax shots, expect the government to allow boosters sometime early next year.
Dr. Reddy's Laboratories says it is in talks with India's drug regulator to sell Russia's Sputnik Light as a booster dose.
Indian states had more than 216 million vaccine doses in stock as of early Monday. India's vaccine output has more than tripled since April to around 300 million doses a month.
Jordan army officer killed in shooting along border with Syria
Death toll from unrest in Kazakhstan rises to 225
India extends ban on political rallies till Jan 22
Singapore backs continued exclusion of Myanmar junta from ASEAN meetings
North Korean hackers stole $400m in 2021
China records 165 new Covid cases for Jan 14 vs 201 a day earlier
China slams US sanctions on Iran as 25-year cooperation agreement launched
Pakistan launches security policy focusing on peace, economic connectivity
Rohingya genocide case: Fresh round of hearings begins Feb 21
Philippines bans unvaccinated from public transport